Home > Annual Financials > CORAL LABORATORIES

CORAL LABORATORIES Financial Statement Analysis
[BOM: 524506]

The Revenues of CORAL LABORATORIES have increased by 3.32% YoY .
The Earnings Per Share (EPS) of CORAL LABORATORIES has increased by 144.96 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

CORAL LABORATORIES Last 5 Annual Financial Results
[BOM: 524506]

StandaloneMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹78 Cr₹76 Cr₹97 Cr₹71 Cr₹91 Cr
Expenses ₹74 Cr₹67 Cr₹81 Cr₹65 Cr₹79 Cr
Operating Profit (Excl OI) ₹3.81 Cr₹8.21 Cr₹16 Cr₹5.42 Cr₹12 Cr
Other Income ₹6.90 Cr₹4.81 Cr₹3.77 Cr₹5.89 Cr₹5.16 Cr
Interest ₹0.34 Cr₹0.14 Cr₹0.04 Cr₹0.19 Cr₹0.17 Cr
Depreciation ₹2.18 Cr₹1.99 Cr₹1.98 Cr₹2.01 Cr₹1.90 Cr
Profit Before Tax ₹8.23 Cr₹12 Cr₹18 Cr₹9.12 Cr₹16 Cr
Profit After Tax ₹6.45 Cr₹9.05 Cr₹14 Cr₹7.13 Cr₹10 Cr
Earnings Per Share (Rs)₹44.19₹18.04₹25.32₹37.94₹19.96
PAT Margin (%)18.878.2511.9614.0410.10
ROE(%)9.504.156.1810.746.22
ROCE(%)12.485.417.8713.357.86
Total Debt/Equity(x)0.000.000.040.050.05

Key Financials

Market Cap : ₹ 252.5 Cr
Revenue (TTM) : ₹ 115.8 Cr
Net Profit(TTM) : ₹ 27.1 Cr
EPS (TTM) : ₹ 75.3
P/E (TTM) : 9.3

Industry Peers & Returns1W1M1Y
CORAL LABORATORIES -4.8% -12.1% 82.8%
SUN PHARMACEUTICAL INDUSTRIES -2.8% 7.6% 8.4%
DIVIS LABORATORIES -2.3% 0.8% 72.7%
CIPLA -5.4% -1.5% 0.8%
TORRENT PHARMACEUTICALS -0.8% 6.8% 25.6%
DR REDDYS LABORATORIES -5.5% 1.6% -5.1%
MANKIND PHARMA 2.1% 3.7% 9.5%
ZYDUS LIFESCIENCES -4.4% 0.4% -12.5%
LUPIN -4.5% 6.9% 25.2%


CORAL LABORATORIES Revenues
[BOM: 524506]

Y-o-Y

3.32 %

5 Yr CAGR

-3.77 %

Years Revenues % Change
Mar2024 ₹78 Cr
3.32
Mar2023 ₹76 Cr
-21.70
Mar2022 ₹97 Cr
36.82
Mar2021 ₹71 Cr
-22.51
Mar2020 ₹91 Cr -


CORAL LABORATORIES Operating Profit
[BOM: 524506]

Y-o-Y

-53.59 %

5 Yr CAGR

-25.57 %

Years Operating Profit % Change
Mar2024 ₹3.81 Cr
-53.59
Mar2023 ₹8.21 Cr
-48.17
Mar2022 ₹16 Cr
192.26
Mar2021 ₹5.42 Cr
-56.34
Mar2020 ₹12 Cr -

Operating Margins
Y-o-Y

-55.06 %

5 Yr CAGR

-22.66 %

Years Operating Margin% % Change
Mar2024 4.88%
-55.06
Mar2023 10.86%
-33.82
Mar2022 16.41%
113.67
Mar2021 7.68%
-43.70
Mar2020 13.64% -

CORAL LABORATORIES Profit After Tax
[BOM: 524506]

Y-o-Y

-28.75 %

5 Yr CAGR

-10.88 %

Years Profit After Tax % Change
Mar2024 ₹6.45 Cr
-28.75
Mar2023 ₹9.05 Cr
-33.26
Mar2022 ₹14 Cr
90.11
Mar2021 ₹7.13 Cr
-30.21
Mar2020 ₹10 Cr -

PAT Margins
Y-o-Y

128.73 %

5 Yr CAGR

16.91 %

Years PAT Margin(%) % Change
Mar2024 18.87 %
128.73
Mar2023 8.25 %
-31.02
Mar2022 11.96 %
-14.81
Mar2021 14.04 %
39.01
Mar2020 10.1 % -

CORAL LABORATORIES Earnings Per Share (EPS)
[BOM: 524506]

Y-o-Y

144.96 %

5 Yr CAGR

21.98 %

Years EPS % Change
Mar2024 ₹44
144.96
Mar2023 ₹18
-28.75
Mar2022 ₹25
-33.26
Mar2021 ₹38
90.08
Mar2020 ₹20 -

CORAL LABORATORIES Return on Capital Employed (ROCE)
[BOM: 524506]

Y-o-Y

130.68 %

5 Yr CAGR

12.25 %

Years ROCE % Change
Mar2024 12.48%
130.68
Mar2023 5.41%
-31.26
Mar2022 7.87%
-41.05
Mar2021 13.35%
69.85
Mar2020 7.86% -

CORAL LABORATORIES Share Price vs Sensex

Current Share Price : ₹701.4
Current MarketCap: ₹ 252.5 Cr
Updated EOD on :Mar 28,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
CORAL LABORATORIES

-4.8%

-12.1%

82.8%

SENSEX

0.7%

4%

6.3%

CORAL LABORATORIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about CORAL LABORATORIES Financials


How the annual revenues of CORAL LABORATORIES have changed ?

The Revenues of CORAL LABORATORIES have increased by 3.32% YoY .

How the Earnings per Share (EPS) of CORAL LABORATORIES have changed?

The Earnings Per Share (EPS) of CORAL LABORATORIES has increased by 144.96 % YoY .